The 2024 National Medical Insurance Catalog released today shows that Johnson & Johnson's two innovative drugs, Zekesudalei Tu Youdan antibody injection (subcutaneous injection) and Shanjiuda Palmiribosone injection (6M), have been included in the medical insurance catalog. Two original products in the catalog, Shantuoda Palmiribosone injection (3M) and Tenoyaguseqi Youdan antibody injection, have been renewed.
强生2款创新药物纳入新版国家医保目录
Two innovative drugs from johnson & johnson have been included in the new national medical insurance catalog.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.